Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

Table 2

Multivariate analysis for cancer-specific survival.

	HR	95%CI lower	95%CI upper	p value
Gleason Sum ≥9	0.50	0.19	1.32	0.164
Performance Status	1.12	0.52	2.41	0.756
Visceral metastasis	0.53	0.11	2.51	0.428
Pre docetaxel chemotherapy	4.80	1.54	14.98	0.006
NLR≥2.14	8.26	1.59	42.76	0.011